ST6GAL1 and cancer: Accumulating evidence shows that ST6GAL1 is aberrantly expressed in various cancer entities such as colon, breast, and epithelial tumor types [14, 17], and most studies propose an oncogenic role for ST6GAL1 [16–20, 28].